|
|
The significance of ultrastructuralelectron microscopy diagnosis in pituitary adenomas |
YANG Zhijun ZHOU Qiangyi WANG Zhenmin LI Peng WANG Bo LIU Pi′nan▲ |
Department of Neurosurgery , Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China |
|
|
Abstract Objective To investigate the significance and perspective of ultrastructural characteristics in diagnosis of pituitary adenoma. Methods From August 2010 to August 2015, the specimens of 112 patients with pituitary adenoma at the Department of Neurosurgery, Beijing Tiantan Hospital were analyzed retrospectively. Making a comparison of the routine pathology approaches and electron microscope in diagnosis of pituitary adenoma. Results In 112 pituitary adenoma species, 47 tumors met the routine criterion of clinically non-functioning adenoma. Within those tumors, 20 were diagnosed as clinically nonfunctioning adenoma by electron microscope, the others including 21 oncocytoma subtype of non-functioning pituitary adenomas, 3 stem cell adenomas, 2 gonadotropins adenomas and 1 mixed type adenoma. Besides, 65 tumors met the routine criterion of functional pituitary adenoma, including 10 prolactinomas, 15 growth hormone-producing adenomas, 5 ACTH-secreting adenomas, 2 gonadotropins adenomas, 2 TSH-secreting adenomas, 1 stem cell adenoma and 30 mixed type adenomas by electron microscope. Conclusion Evaluation of ultrastructural characteristics evaluating of pituitary adenomas can provide extraordinary information, which has contributed considerably to the diagnosis of pituitary adenomas.
|
|
|
|
|
[1] 王忠诚.神经外科学[M].武汉:湖北科学技术出版社,1998.
[2] 臧旭,张淑英,张淑华,等.垂体腺瘤——150例光镜和电镜病理分析[J].中华病理学杂志,1985,14(4):274-278.
[3] 毛棣华,惠国桢.脑垂体腺瘤156例免疫组化及超微结构研究[J].苏州大学学报:医学版,1995(3):417-420.
[4] Horvath E,Kovacs K. Ultrastructural diagnosis of human pituitary adenomas [J]. Microsc Res Tech,1992,20(2):107.
[5] Pawlikowski M,Kunertradek J, Radek M. Plurihormonality of pituitary adenomas in light of immunohistochemical studies [J]. Endokrynol Pol,2010,61(1):63.
[6] 姜晓华,蔡洁,王卫庆,等.垂体促甲状腺素瘤的临床特点与诊治分析[J].中华内分泌代谢杂志,2012,28(9):729-733.
[7] Luk CT,Kovacs K,Rotondo F, et al. Plurihormonal pituitary adenoma immunoreactive for thyroid-stimulating hormone, growth hormone, follicle-stimulating hormone, and prolactin [J]. Endocr Pract, 2012,18(5):121-126.
[8] 郭凌川,郑玉双,惠国桢,等.垂体腺瘤细胞形态变化及Ki-67、MMP-9蛋白表达与肿瘤侵袭性的临床病理研究[J].中华神经外科杂志,2013,29(5):465-468.
[9] Dekkers OM,Pereira AM,Roelfsema F,et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma [J]. J Clin Endocrinol Metab,2006, 91(5):1796-1801.
[10] 阎晓玲.促性腺激素腺瘤[J].中国现代神经疾病杂志,2015,15(11):903.
[11] 包明月,程宏伟.垂体瘤治疗现况及进展[J].中华临床医师杂志:电子版,2013,(6):2647-2649.
[12] Kovacs K,Lloyd R,Horvath E,et al. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy,in vitro examination, and in situ hybridization [J]. AJP,1989,134(2):345-353.
[13] Wade AN,Baccon J,Grady MS,et al. Clinically silent somatotroph adenomas are common [J]. Eur J Endocrinol,2011,165(1):39-44.
[14] Cooper O. Silent Corticotroph Adenomas [J]. Pituitary,2015, 18(2):225-231.
[15] Mete O,Gomez-Hernandez K,Kucharczyk W,et al. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas [J]. Mod Pathol,2016,29(2):131-142.
[16] Gomez-Hernandez K,Ezzat S,Asa SL,et al. Clinical implications of accurate subtyping of pituitary adenomas:perspectives from the treating physician[J].Turk Patoloji Derg,2015,31(Suppl 1):4-17.
[17] Louis DN,Ohgaki H,Wiestler OD,et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol,2007,114(2):97-109.
[18] 吴永刚,洪礼传,冯洁,等.CLDN9基因与垂体瘤样细胞瘤侵袭相关性的实验研究[J].中华神经外科杂志,2016, 32(12):1278-1282.
[19] 李剑瑜,刘鹏年,张霞,等.三七皂甙Rg1、Rb1对肝纤维化大鼠线粒体DNA三磷酸腺苷酶6、8亚基的作用机制研究[J].环球中医药,2014,7(8):591-595.
[20] 唐美岸,何振华,张秀峰,等.苦参碱对肺纤维化大鼠肺线粒体氧化应激的影响[J].广东医学,2012,33(2):182-185.
[21] 黄继义,林鹰,逯富华,等.肾小管上皮细胞线粒体氧化损伤在肾间质纤维化中的病理学机制研究[J].北方药学,2016,13(1):103-105. |
|
|
|